Advertisement
Advertisement
89bio downgraded to Market Perform from Outperform at Raymond James
PremiumThe Fly89bio downgraded to Market Perform from Outperform at Raymond James
2M ago
89bio downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
89bio downgraded to Neutral from Buy at H.C. Wainwright
2M ago
89bio downgraded to Peer Perform from Outperform at Wolfe Research
Premium
The Fly
89bio downgraded to Peer Perform from Outperform at Wolfe Research
2M ago
Roche enters into definitive merger agreement to acquire 89bio
PremiumThe FlyRoche enters into definitive merger agreement to acquire 89bio
2M ago
Strategic Acquisition of 89bio by Roche Highlights Promising Growth in MASH and FGF21 Market
Premium
Ratings
Strategic Acquisition of 89bio by Roche Highlights Promising Growth in MASH and FGF21 Market
2M ago
M&A News: 89bio Stock (ETNB) Jumps 83% on $3.5B Acquisition by Roche
Premium
Market News
M&A News: 89bio Stock (ETNB) Jumps 83% on $3.5B Acquisition by Roche
2M ago
89bio reports Q2 EPS (71c), consensus (48c)
PremiumThe Fly89bio reports Q2 EPS (71c), consensus (48c)
3M ago
89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment
Premium
Company Announcements
89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment
3M ago
89bio Elects Directors and Approves Proposals at Annual Meeting
Premium
Company Announcements
89bio Elects Directors and Approves Proposals at Annual Meeting
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100